» Articles » PMID: 31321851

Cancer and Heart Disease: Associations and Relations

Overview
Publisher Wiley
Date 2019 Jul 20
PMID 31321851
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging evidence supports that cancer incidence is increased in patients with cardiovascular (CV) disease and heart failure (HF), and patients with HF frequently die from cancer. Recently, data have been generated showing that circulating factors in relation to HF promote tumour growth and development in murine models, providing proof that a causal relationship exists between both diseases. Several common pathophysiological mechanisms linking HF to cancer exist, and include inflammation, neuro-hormonal activation, oxidative stress and a dysfunctional immune system. These shared mechanisms, in combination with risk factors, in concert may explain why patients with HF are prone to develop cancer. Investigating the new insights linking HF with cancer is rapidly becoming an exciting new field of research, and we herein review the most recent data. Besides insights in mechanisms, we call for clinical awareness, that is essential to optimize treatment strategies of patients having developed cancer with a history of HF. Finally, ongoing and future trials should strive for comprehensive phenotyping of both CV and cancer end points, to allow optimal usefulness of data, and to better describe and understand common characteristics of these two lethal diseases.

Citing Articles

Accelerated Coronary Artery Disease in a Patient With Advanced Lung Cancer: Interplay of Cancer, Inflammation, and Treatment Effects.

Tolu-Akinnawo O, Ogunniyi K Cureus. 2025; 17(1):e77769.

PMID: 39981449 PMC: 11841481. DOI: 10.7759/cureus.77769.


Artificial Intelligence Applications in Cardio-Oncology: A Comprehensive Review.

Guha A, Shah V, Nahle T, Singh S, Kunhiraman H, Shehnaz F Curr Cardiol Rep. 2025; 27(1):56.

PMID: 39969610 DOI: 10.1007/s11886-025-02215-w.


Cardiovascular health: an important component of cancer survivorship.

Cleary S, Rosen S, Gilbert D, Langley R BMJ Oncol. 2025; 2(1):e000090.

PMID: 39886493 PMC: 11235026. DOI: 10.1136/bmjonc-2023-000090.


Cardiovascular Disease and Breast Cancer: Exploring 2 Interconnected Landscapes.

Vo J, Roger V JACC CardioOncol. 2025; 6(6):904-906.

PMID: 39801635 PMC: 11711825. DOI: 10.1016/j.jaccao.2024.10.008.


Cardiovascular Disease and Cancer: A Dangerous Liaison.

Newman A, Dalman J, Moore K Arterioscler Thromb Vasc Biol. 2025; 45(3):359-371.

PMID: 39781742 PMC: 11864891. DOI: 10.1161/ATVBAHA.124.319863.


References
1.
Takimoto E, Kass D . Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension. 2006; 49(2):241-8. DOI: 10.1161/01.HYP.0000254415.31362.a7. View

2.
Herrmann J, Lerman A, Sandhu N, Villarraga H, Mulvagh S, Kohli M . Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clin Proc. 2014; 89(9):1287-306. PMC: 4258909. DOI: 10.1016/j.mayocp.2014.05.013. View

3.
Ameri P, Canepa M, Anker M, Belenkov Y, Bergler-Klein J, Cohen-Solal A . Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge. Eur J Heart Fail. 2018; 20(5):879-887. DOI: 10.1002/ejhf.1165. View

4.
van Woerden G, Gorter T, Westenbrink B, Willems T, Van Veldhuisen D, Rienstra M . Epicardial fat in heart failure patients with mid-range and preserved ejection fraction. Eur J Heart Fail. 2018; 20(11):1559-1566. PMC: 6607508. DOI: 10.1002/ejhf.1283. View

5.
Wolin K, Carson K, Colditz G . Obesity and cancer. Oncologist. 2010; 15(6):556-65. PMC: 3227989. DOI: 10.1634/theoncologist.2009-0285. View